A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Article
en En
| MEDLINE
| ID: mdl-33152285
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Pronóstico
/
Neoplasias de la Mama
/
Receptor ErbB-2
/
Trastuzumab
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Lancet Oncol
Asunto de la revista:
NEOPLASIAS
Año:
2020
Tipo del documento:
Article